151 related articles for article (PubMed ID: 21195931)
1. New insight on vitamin C in patients with chronic kidney disease.
Handelman GJ
J Ren Nutr; 2011 Jan; 21(1):110-2. PubMed ID: 21195931
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
3. Newer strategies for anemia prevention in hemodialysis.
Handelman GJ
Int J Artif Organs; 2007 Nov; 30(11):1014-9. PubMed ID: 18067104
[TBL] [Abstract][Full Text] [Related]
4. Vitamin C deficiency in dialysis patients--are we perceiving the tip of an iceberg?
Handelman GJ
Nephrol Dial Transplant; 2007 Feb; 22(2):328-31. PubMed ID: 17107966
[No Abstract] [Full Text] [Related]
5. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Overview of anemia associated with chronic renal disease: primary and secondary mechanisms.
Paganini EP
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):3-8. PubMed ID: 2648518
[TBL] [Abstract][Full Text] [Related]
8. [Oral administration of iron with vitamin C in haemodialyzed patients].
Derzsiová K; Mydlík M; Boldizsár J; Hríbiková M; Petrovicová J
Vnitr Lek; 2001 Apr; 47(4):210-4. PubMed ID: 15635885
[TBL] [Abstract][Full Text] [Related]
9. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study.
Sirover WD; Siddiqui AA; Benz RL
Ren Fail; 2008; 30(9):884-9. PubMed ID: 18925528
[TBL] [Abstract][Full Text] [Related]
10. Anemia of renal failure. A review.
Diaz-Buxo JA; Frohnert PP
Minn Med; 1974 May; 57(5):374-8. PubMed ID: 4824718
[No Abstract] [Full Text] [Related]
11. Is vitamin C intake too low in dialysis patients?
Raimann JG; Levin NW; Craig RG; Sirover W; Kotanko P; Handelman G
Semin Dial; 2013; 26(1):1-5. PubMed ID: 23106569
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients.
Taji Y; Morimoto T; Okada K; Fukuhara S; Fukui T; Kuwahara T
J Nephrol; 2004; 17(4):537-43. PubMed ID: 15372416
[TBL] [Abstract][Full Text] [Related]
13. [Anemia in patients treated with periodic hemodialysis. Therapeutic criteria and long-term results].
Bucciante G; Frizzi V; Bernardi AM; Amadori G
Minerva Urol; 1978; 30(2):85-95. PubMed ID: 703731
[No Abstract] [Full Text] [Related]
14. Vitamin C neglect in hemodialysis: sailing between Scylla and Charybdis.
Handelman GJ
Blood Purif; 2007; 25(1):58-61. PubMed ID: 17170539
[TBL] [Abstract][Full Text] [Related]
15. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis.
Berns JS; Mosenkis A
Hemodial Int; 2005 Jan; 9(1):7-22. PubMed ID: 16191049
[TBL] [Abstract][Full Text] [Related]
17. Oral or parenteral iron therapy in haemodialysis patients?
Winney RJ; Swainson CP; Parker AC; Bone JM; Robson JS
Proc Eur Dial Transplant Assoc; 1977; 14():184-91. PubMed ID: 600955
[TBL] [Abstract][Full Text] [Related]
18. [Issues related to iron replacement in dialyzed patients].
Kessler M
Nephrol Ther; 2006 Sep; 2 Suppl 4():S266-73. PubMed ID: 17373269
[TBL] [Abstract][Full Text] [Related]
19. [How do we optimally evaluate iron stores in dialyzed patients treated with erythropoiesis stimulating agent?].
Kessler M; Salignac S; Aimone-Gastin I
Nephrol Ther; 2006 Sep; 2 Suppl 4():S261-5. PubMed ID: 17373268
[TBL] [Abstract][Full Text] [Related]
20. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
